A Phase 1 Study of Molnupiravir, The First Approved Oral COVID-19 Therapy, in Japanese Healthy Participants: Study Design and Safety
- Resource Type
- Journal Article
- Source
- Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics. 2022, :1-029
- Subject
- Language
- Japanese
- ISSN
- 2436-5580